I'm sure you've all gotten the press release from PTC. PTC124 has been given an actual name: Ataluren.
"The United States Adopted Names Council (USAN) in conjunction with the World Health Organization, International Nonproprietary Names Committee deemed ataluren's mechanism of action to be significantly novel, warranting creation of a new stem, -luren, for pharmaceuticals that are inducers of ribosomal readthrough of nonsense mutation mRNA stop codons."

I didn't realize there were actual rules to the names... I figured somebody at the developing company named them...

http://ptct.client.shareholder.com/releasedetail.cfm?ReleaseID=363177

~P